2023 - Research.com Microbiology in United States Leader Award
2011 - Fellow of the American Association for the Advancement of Science (AAAS)
His scientific interests lie mostly in Mycobacterium tuberculosis, Microbiology, Tuberculosis, Virology and Genetics. The concepts of his Mycobacterium tuberculosis study are interwoven with issues in Isoniazid and Biochemistry, Gene, Virulence. The study incorporates disciplines such as Mycobacterium, Mutagenesis, Mutant, Mycobacterium smegmatis and In vivo in addition to Microbiology.
His Tuberculosis study also includes fields such as
William R. Jacobs mainly investigates Mycobacterium tuberculosis, Microbiology, Tuberculosis, Virology and Biochemistry. His Mycobacterium tuberculosis study incorporates themes from Gene, Virulence, Drug resistance and Isoniazid. His Gene research is within the category of Genetics.
His Microbiology study which covers Mycobacterium smegmatis that intersects with Plasmid. His Tuberculosis research integrates issues from Pathogen, Immunology, Antibiotics and Auxotrophy. William R. Jacobs interconnects Immune system, Immunity and Antigen in the investigation of issues within Virology.
William R. Jacobs mostly deals with Mycobacterium tuberculosis, Microbiology, Virology, Tuberculosis and Immune system. His Mycobacterium tuberculosis research incorporates themes from Biochemistry, Enzyme, Isoniazid, In vivo and Virulence. He has researched Microbiology in several fields, including Biofilm, Bacteria, Oxidative stress and Mutant.
His study in Virology is interdisciplinary in nature, drawing from both T cell and Antigen. Rifampicin is closely connected to Drug resistance in his research, which is encompassed under the umbrella topic of Tuberculosis. William R. Jacobs combines subjects such as Receptor and Mycobacterium bovis with his study of Immune system.
William R. Jacobs focuses on Mycobacterium tuberculosis, Microbiology, Tuberculosis, Virology and Immunology. His biological study spans a wide range of topics, including NADH dehydrogenase, Oxidative phosphorylation, Biochemistry, Enzyme and Antigen presentation. His Microbiology study incorporates themes from Oxidative stress, Reactive oxygen species, Mutant, Bacteria and In vivo.
In general Tuberculosis, his work in Isoniazid is often linked to Global health linking many areas of study. His work carried out in the field of Virology brings together such families of science as Spleen, Immunity and Effector. In his research, Cytokine is intimately related to Mycobacterium bovis, which falls under the overarching field of Immune system.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Effect of vasodilator therapy on mortality in chronic congestive heart failure. Results of a Veterans Administration Cooperative Study.
Jay N. Cohn;Donald G. Archibald;Susan Ziesche;Joseph A. Franciosa.
The New England Journal of Medicine (1986)
inhA, a gene encoding a target for isoniazid and ethionamide in Mycobacterium tuberculosis
A. Banerjee;E. Dubnau;A. Quemard;V. Balasubramanian.
Science (1994)
New use of BCG for recombinant vaccines.
C. K. Stover;V. F. De La Cruz;T. R. Fuerst;J. E. Burlein.
Nature (1991)
Persistence of Mycobacterium tuberculosis in macrophages and mice requires the glyoxylate shunt enzyme isocitrate lyase
John D. McKinney;John D. McKinney;John D. McKinney;Kerstin Höner Zu Bentrup;Kerstin Höner Zu Bentrup;Kerstin Höner Zu Bentrup;Ernesto J. Muñoz-Elias;Andras Miczak;Andras Miczak.
Nature (2000)
Isolation and characterization of efficient plasmid transformation mutants of Mycobacterium smegmatis.
S. B. Snapper;R. E. Melton;S. Mustafa;T. Kieser.
Molecular Microbiology (1990)
An Outbreak of Tuberculosis With Accelerated Progression Among Persons Infected With the Human Immunodeficiency Virus. An Analysis Using Restriction-Fragment-Length Polymorphisms
Charles L. Daley;Peter M. Small;Gisela F. Schecter;Gary K. Schoolnik.
The New England Journal of Medicine (1992)
Effect of Vasodilator Therapy on Mortality in Chronic Congestive Heart Failure. Results of a Veterans Administration Cooperative Study
J. Cohn;D. Archibald;S. Ziesche;J. Franciosa.
Survey of Anesthesiology (1987)
Whole-Genome Comparison of Mycobacterium tuberculosis Clinical and Laboratory Strains
R. D. Fleischmann;D. Alland;Jonathan A Eisen;L. Carpenter.
Journal of Bacteriology (2002)
Complex lipid determines tissue-specific replication of Mycobacterium tuberculosis in mice
Jeffery S. Cox;Bing Chen;Michael McNeil;William R. Jacobs.
Nature (1999)
Modification of the NADH of the Isoniazid Target (InhA) from Mycobacterium tuberculosis
Denise A. Rozwarski;Gregory A. Grant;Derek H. R. Barton;William R. Jacobs.
Science (1998)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
Harvard University
Albert Einstein College of Medicine
Texas A&M University
University of Pittsburgh
Albert Einstein College of Medicine
Institut de Recherche en Infectiologie de Montpellier (IRIM)
University of Birmingham
Duke University
Beth Israel Deaconess Medical Center
Rutgers, The State University of New Jersey
University of Alberta
Kyoto University
Wuhan University
Princeton University
University of Minnesota
Pompeu Fabra University
University of Sydney
Kettering University
Uppsala University
Chinese Academy of Sciences
Israel Oceanographic and Limnological Research
Iowa State University
Boğaziçi University
Federal University of Sao Paulo
University of Maryland, College Park
The University of Texas Health Science Center at Houston